NCT02517385View on ClinicalTrials.gov

Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases

PHASE3CompletedINTERVENTIONAL

Enrollment

147

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Hepatic and Hepatobiliary Disorders

Interventions

DRUG

Phosphatidylcholine

Pharmaceutical form:Paste Route of administration: Oral

Trial Locations (1)

Unknown

Moscow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY